Pharma-Bio Serv (PBSV) Free Cash Flow (2010 - 2026)
Pharma-Bio Serv (PBSV) reported Free Cash Flow of -$367632.0 for Q2 2026, down 20.2% year-over-year from -$460696.8 in Q2 2025, and up 6.35% on a QoQ basis from -$392550.0 in Q1 2026.
Pharma-Bio Serv (PBSV) Free Cash Flow (2010 - 2026) Analysis & Trends
Pharma-Bio Serv's Free Cash Flow history runs 17 years deep, the most recent figure standing at -$367632.0 for Q2 2026.
- Free Cash Flow for Q2 2026 came in at -$367632.0, down 20.2% year-over-year; the trailing twelve-month figure through Apr 2026 was -$246378.0 (up 83.42% YoY), and the FY2025 annual result was -$221530.0, up 69.5% from the prior year.
- Free Cash Flow came in at -$367632.0 for Q2 2026 at Pharma-Bio Serv, up from -$392550.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $1.1 million in Q3 2022 to a low of -$700744.0 in Q2 2024.
- A 5-year average of $41596.7 and a median of -$164730.5 in 2023 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow plunged 179.32% in 2024 and surged 455.41% in 2025, its largest moves.
- Over 5 years, Free Cash Flow stood at $247954.0 in 2022, then gained by 25.03% to $310016.0 in 2023, then sank by 125.35% to -$78590.0 in 2024, then surged by 455.41% to $279316.0 in 2025, then tumbled by 231.62% to -$367632.0 in 2026.
- The last three Free Cash Flow figures came in at -$367632.0 (Q2 2026), -$392550.0 (Q1 2026), and $279316.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 1.13 Bn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 119.28 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 81.60 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 43.06 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 26.00 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 107.27 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 69.59 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | -49.47 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 42.07 Mn |
| 10 | Pharma-Bio Serv | - | - | 902,041.00 | -367,632.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -367,632.00 |
| Apr 30, 2026 | -367,632.00 |
| Jan 31, 2026 | -392,550.00 |
| Jan 31, 2026 | -392,550.00 |
| Oct 31, 2025 | 279,316.00 |
| Oct 31, 2025 | 279,316.00 |
| Jul 31, 2025 | 234,488.00 |
| Jul 31, 2025 | 234,488.00 |
| Apr 30, 2025 | -305,848.00 |
| Apr 30, 2025 | -305,848.00 |
| Jan 31, 2025 | -429,486.00 |
| Jan 31, 2025 | -429,486.00 |
| Oct 31, 2024 | -78,590.00 |
| Oct 31, 2024 | -78,590.00 |
| Jul 31, 2024 | -672,235.00 |
| Jul 31, 2024 | -672,235.00 |
| Apr 30, 2024 | -700,744.00 |
| Apr 30, 2024 | -700,744.00 |
| Jan 31, 2024 | 725,125.00 |
| Jan 31, 2024 | 725,125.00 |